IMMUNOCHEMOTHERAPY

Clinical trials for IMMUNOCHEMOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new IMMUNOCHEMOTHERAPY trials appear

Sign up with your email to follow new studies for IMMUNOCHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to stop cervical Cancer's return

Disease control Recruiting now

This study is testing whether adding an immunotherapy drug (camrelizumab) to standard chemotherapy helps prevent cervical cancer from returning after surgery, specifically for patients whose cancer had spread to their lymph nodes. It will follow 59 participants for three years to…

Matched conditions: IMMUNOCHEMOTHERAPY

Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

IMMUNOCHEMOTHERAPY

Get alerted when new IMMUNOCHEMOTHERAPY trials appear

New drug combo aims to stop cervical Cancer's return